These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 10213023
1. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Andrade SE, Gurwitz JH, Fish LS. Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023 [Abstract] [Full Text] [Related]
2. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Gurwitz JH, McLaughlin TJ, Fish LS. Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226 [Abstract] [Full Text] [Related]
3. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Kalish SC, Bohn RL, Avorn J. Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201 [Abstract] [Full Text] [Related]
4. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization. Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB. Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957 [Abstract] [Full Text] [Related]
5. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation? Menees SB, Guentner A, Chey SW, Saad R, Chey WD. Am J Gastroenterol; 2015 Nov; 110(11):1516-25. PubMed ID: 26054623 [Abstract] [Full Text] [Related]
6. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis. Shih YC, Prasad M, Luce BR. Clin Ther; 2002 Apr; 24(4):701-16. PubMed ID: 12017413 [Abstract] [Full Text] [Related]
7. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Altman KW, Stephens RM, Lyttle CS, Weiss KB. Laryngoscope; 2005 Jul; 115(7):1145-53. PubMed ID: 15995499 [Abstract] [Full Text] [Related]
9. General practitioners' views on the over-the-counter availability of H2-antagonists. Erwin J, Britten N, Jones R. Br J Gen Pract; 1997 Feb; 47(415):99-102. PubMed ID: 9101694 [Abstract] [Full Text] [Related]
12. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation. Tasch RF, Goeree R, Henke CJ, O'Brien BJ. Pharmacoeconomics; 1996 Jan; 9(1):61-75. PubMed ID: 10160088 [Abstract] [Full Text] [Related]
13. Elimination of over-the-counter medication coverage in the Oregon Medicaid population: the impact on program costs and drug use. Zechnich AD, Greenlick M, Haxby D, Mullooly J. Med Care; 1998 Aug; 36(8):1283-94. PubMed ID: 9708599 [Abstract] [Full Text] [Related]
17. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change. Ramser KL, Sprabery LR, Hamann GL, George CM, Will A. J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274 [Abstract] [Full Text] [Related]
18. Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior. Lacy BE, Crowell MD, Riesett RP, Mitchell A. J Clin Gastroenterol; 2005 Jul; 39(6):489-94. PubMed ID: 15942434 [Abstract] [Full Text] [Related]